Nuvation Bio (NUVB) Q1 2025 Earnings
NUVB·Reported May 7, 2025·After market close
Nuvation Bio reported Q1 2025 revenue of $3.1M, beat analyst consensus of $357.1K by $2.7M. Diluted EPS came in at $-0.16 (-128.6% YoY).
Revenue
$3.1Mbeat by $2.7M
Consensus: $357.1KDiluted EPS
$-0.16met estimate
Consensus: $-0.16
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Nuvation Bio's Q1 2025 earnings report.
Nuvation Bio (NUVB) reported Q1 2025 earnings on May 7, 2025 after market close.
Nuvation Bio reported revenue of $3.1M and diluted EPS of $-0.16 for Q1 2025.
Revenue beat the consensus estimate of $357.1K by $2.7M. EPS beat the consensus estimate of $-0.16 by $0.00.
Compared to the same quarter a year prior, diluted EPS declined 128.6% from $-0.07.
You can read the 10-Q periodic report (0000950170-25-065712) directly on SEC EDGAR. The filing index links above go to sec.gov.